Federal contract award
75A50124F61002
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
| Parent award / vehicle | 75A50123D00003 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $304.0M |
| Current contract value | $304.0M |
| Potential contract value / ceiling | $376.0M |
| Start date | Jan 12, 2024 |
| Current end date | Mar 1, 2030 |
| Potential end date | Mar 1, 2030 |
| Latest award activity | Mar 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 4, 2026 | P00010 | $0 | OTA: THE PURPOSE OF THIS MODIFICATION IS TO REVISE THE TASK ORDER AGREEMENT PERIOD OF PERFORMANCE AT NO ADDITIONAL COST TO THE GOVERNMENT. |
| Feb 2, 2026 | P00009 | $210.0M | OTA: THE PURPOSE OF THIS MODIFICATION IS TO INCREASE THE TOTAL ESTIMATED COST AND ADD FUNDING. |
| Jan 30, 2026 | P00008 | $15.0M | OTA: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE, INCLUDING LINES 1, 2, AND 7-12, INCREASE THE OVERALL CEILING VALUE AND ADD FUNDING. |
| Oct 22, 2025 | P00007 | $0 | OTA: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLE 7.3 ADMINISTRATIVE MATTERS: OTHER TRANSACTION AGREEMENTS OFFICER (OTAO). |
| Mar 13, 2025 | P00006 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY CHANGE SECTION 7: TASK ORDER POINTS OF CONTACT BY CHANGING THE HHS/ASPR PROJECT AGREEMENT REPRESENTATIVE (PAR) TO PAIGE EZERNACK. |
| Jan 15, 2025 | P00005 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY CHANGE SECTION 7: TASK ORDER POINTS OF CONTACT BY CHANGING THE HHS/ASPR OTHER TRANSACTION AGREEMENTS OFFICER (OTAO) FROM CHRISTOPHER WEAVER TO LORI FISCHER. |
| Dec 10, 2024 | P00004 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO (1) REVISE THE COMPLETION DATE ON THE ORDER TO 12/31/2026, AND (2) TRANSFER TASK ORDER 75A50124F61002 FROM ASPR/BARDA/PCI TO ASPR INDUSTRIAL BASE MANAGEMENT AND SUPPLY CHAIN (IBMSC). |
| Sep 20, 2024 | P00003 | $0 | OTHER TRANSACTION: TO INCORPORATE REVISED ARTICLES 1.5, 2.21, 2.24, 2.26, 2.31, 7.8, 7.8.1, 7.9, 14.1.1, 19.4, AND 19.13 OF OT BASE AGREEMENT 75A50123D00003, DATED AUGUST 29, 2024, BY REFERENCE; AND REVISE THE COMPLETION DATE ON THE ORDER, INCLUDING |
| Sep 12, 2024 | P00002 | $20.0M | OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM |
| Jul 24, 2024 | P00001 | $24.0M | OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM |
| Jan 12, 2024 | 0 | $35.0M | OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM |
Estimated positioning window
Mar 1, 2029 – Sep 1, 2029
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2030-03-01 (1216 days from calculation)
- +5 points
- 8 historical awards in this buyer and category group
- +15 points
- 11 recorded award transactions
- +10 points
- Latest award action: 2026-03-04
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.